Last reviewed · How we verify
Addiclenz (ASPARTAME)
At a glance
| Generic name | ASPARTAME |
|---|---|
| Sponsor | Deseret Biologicals, Inc. |
| Drug class | Standardized Chemical Allergen [EPC] |
| Modality | Small molecule |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
Approved indications
- headache
- liver support
- muscle weakness
- skin irritation
- poor muscle coordination
Common side effects
Key clinical trials
- SweetSpot - The Effect of Non-nutritive Sweeteners on Health (NA)
- Effect of Non-nutritive Sweeteners of High Sugar Sweetened Beverages on Metabolic Health and Gut Microbiome (NA)
- The Effects of Dietary Erythritol on Platelet Reactivity and Vascular Inflammation (NA)
- Satiety and Alcohol Challenge (NA)
- Non-Nutritive Sweetener Consumption and Glucose Homeostasis in Older Adults With Prediabetes (NA)
- Effects of Dietary Nitrate and Vitamin C Co-supplementation on Blood Pressure and Endothelial Function in Overweight Individuals (NA)
- Reproducibility and Utility of OGTT in Acromegaly (NA)
- Health Effects of Substituting Sugary Beverages With Artificially-sweetened Beverages or Water (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Addiclenz CI brief — competitive landscape report
- Addiclenz updates RSS · CI watch RSS
- Deseret Biologicals, Inc. portfolio CI